Hosted on MSN1mon
What Is Chronic Sinusitis, and How Is it Treated?
Chronic sinusitis (also known as chronic rhinosinusitis) is defined as "nasal obstruction, nasal drainage, facial pressure and/or decreased sense of smell, [lasting] for more than 12 weeks ...
Medscape4mon
Sinusitis: A Head and Neck Surgeon's Perspective
If sinus obstruction occurs, the retained secretions create a milieu that is ideal for bacterial growth resulting in bacterial sinusitis. The anterior ethmoid-middle meatal complex (osteomeatal ...
Twice-yearly drug eases symptoms in chronic rhinosinusitis with polyps
An international collaboration of researchers, sponsored by GSK and working on behalf of the ANCHOR-1 and ANCHOR-2 trial ...
GSK's Twice-Yearly Depemokimab Reduces Nasal Polyp Size, Goes Under FDA Review
FDA reviews GSK depemokimab for asthma and CRSwNP, with a decision expected by December 2025. Phase 3 data shows improvements ...
Medscape5d
Efficacy and Tolerability of Moxifloxacin in Patients With Sinusitis Treated in General Practice
Symptoms of sinusitis (fever, cough, nasal obstruction, nasal secretion and headache) were assessed at baseline and at follow-up visits, and classified as 'absent', 'mild' or 'severe' by the ...
MPR6d
FDA to Review Depemokimab for Asthma With Eosinophilic Phenotype, CRSwNP
The Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for depemokimab for asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps ...
PharmExec12d
FDA Accepts Biologics License Application for GSK’s Depemokimab for Asthma with Type 2 Inflammation and CRSwNP
In the SWIFT and ANCHOR trials, depemokimab demonstrated statistically significant reductions in nasal polyp size, ...